JDEAX
Price
$51.11
Change
-$0.39 (-0.76%)
Updated
Jul 13 closing price
Net Assets
12.03B
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

JDEAX vs VSTSX

JDEAX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
JDEAX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDEAX is a Buy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. JDEAX (12B). VSTSX pays higher dividends than JDEAX: VSTSX (1.07) vs JDEAX (0.51). JDEAX was incepted earlier than VSTSX: JDEAX (25 years) vs VSTSX (10 years). JDEAX (0.84) is less costly to investors than VSTSX (0.01). JDEAX is a more actively managed with annual turnover of: 28.00 vs. VSTSX (3.00). JDEAX has a lower initial minimum investment than VSTSX: JDEAX (1000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. JDEAX (13.67). VSTSX return over 5 years is better than : 66.56 vs. JDEAX (42.71).
JDEAXVSTSXJDEAX / VSTSX
Total Expense Ratio0.600.016,000%
Annual Report Gross Expense Ratio0.840.018,400%
Fund Existence25 years10 years-
Gain YTD9.23211.20582%
Front Load5%N/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets12B2.3T1%
Annual Yield % from dividends0.511.0748%
Returns for 1 year13.6721.4864%
Returns for 3 years53.5367.0680%
Returns for 5 years42.7166.5664%
Returns for 10 years148.92239.5362%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I